Racial and gender disparities in receipt of highly active antiretroviral therapy persist in a multistate sample of HIV patients in 2001.
about
Widening of socioeconomic inequalities in U.S. death rates, 1993-2001Late HIV diagnosis and determinants of progression to AIDS or death after HIV diagnosis among injection drug users, 33 US States, 1996-2004Severe morbidity according to sex in the era of combined antiretroviral therapy: the ANRS CO3 Aquitaine CohortEstimating the potential pool of HIV-infected deceased organ donors in the United StatesHospital days attributable to immune reconstitution inflammatory syndrome in persons living with HIV before and after the 2012 DHHS HIV guidelines.Enhanced Collection of Laboratory Data in HIV Surveillance Among 5 States with Confidential Name-based HIV Infection Reporting, 2005-2006Empirical use of antibiotics and adjustment of empirical antibiotic therapies in a university hospital: a prospective observational study.Predictors of willingness to use a smartphone for research in underserved persons living with HIV.Illicit drug use, depression and their association with highly active antiretroviral therapy in HIV-positive womenNarrowing the Gap in Life Expectancy Between HIV-Infected and HIV-Uninfected Individuals With Access to CareMental health treatment to reduce HIV transmission risk behavior: a positive prevention modelConspiracy beliefs about HIV are related to antiretroviral treatment nonadherence among african american men with HIV.Methadone maintenance therapy promotes initiation of antiretroviral therapy among injection drug usersGender disparities in HIV health care utilization among the severely disadvantaged: can we determine the reasons?The interplay of sociodemographic factors on virologic suppression among a U.S. outpatient HIV clinic populationGender differences in clinical, immunological, and virological outcomes in highly active antiretroviral-treated HIV-HCV coinfected patientsThe cerebrospinal fluid HIV risk score for assessing central nervous system activity in persons with HIV.Patterns, trends and sex differences in HIV/AIDS reported mortality in Latin American countries: 1996-2007Sex influences immune responses to viruses, and efficacy of prophylaxis and treatments for viral diseasesThe impact of illicit drug use and substance abuse treatment on adherence to HAART.Increase in CD4 count among new enrollees in HIV care in the modern antiretroviral therapy era.Disparities in outcomes for African American and Latino subjects in the Flexible Initial Retrovirus Suppressive Therapies (FIRST) trial.Patient-provider communication differs for black compared to white HIV-infected patients.Race and other risk factors for incident proteinuria in a national cohort of HIV-infected veterans.African American patient experiences with a rapid HIV testing program in an urban public clinic.HIV-infected patients and treatment outcomes: an equivalence study of community-located, primary care-based HIV treatment vs. hospital-based specialty care in the Bronx, New YorkNeighborhood socioeconomic status, race, and mortality in young adult dialysis patients.Impact of gender on response to highly active antiretroviral therapy in HIV-1 infected patients: a nationwide population-based cohort study.Disparities in CD4+ T-Lymphocyte Monitoring Among Human Immunodeficiency Virus-Positive Medicaid Beneficiaries: Evidence of Differential Treatment at the Point of Care.The impact of the AIDS Drug Assistance Program (ADAP) on use of highly active antiretroviral and antihypertensive therapy among HIV-infected womenLow perceived risk and high HIV prevalence among a predominantly African American population participating in Philadelphia's Rapid HIV testing program.Sex, race, and geographic region influence clinical outcomes following primary HIV-1 infectionEmergency department utilization among HIV-infected patients in a multisite multistate studyAntiretroviral therapy: a promising HIV prevention strategy?Substance use and the quality of patient-provider communication in HIV clinics.Association of ongoing drug and alcohol use with non-adherence to antiretroviral therapy and higher risk of AIDS and death: results from ACTG 362.Improved virologic suppression with HIV subspecialty care in a large prison system using telemedicine: an observational study with historical controls.Linkage and retention in HIV care among men who have sex with men in the United States.Linkage to care for HIV-infected heterosexual men in the United StatesMain partner factors associated with worse adherence to HAART among women in Baltimore, Maryland: a preliminary study
P2860
Q21562288-992365B0-05EA-4A4F-B223-753FEF6ACC52Q28474749-DE781807-4F35-4839-98F7-8C8BFF87E0CCQ28541356-DE1931B9-13BB-441D-B46B-C200FB70E999Q28743880-3F780837-96EC-4BD4-8112-1ACA88052C95Q30252460-B771A705-BC13-456D-ACB2-3E5B77E212A0Q30573011-82299B56-645E-40B0-B3D7-6FFF043910F1Q33280031-B517F83D-B107-4FB7-9A55-B9ED8AC0D0C0Q33452454-05C303C4-C157-4516-88BD-D5B3C5B71567Q33563439-6097F473-2221-4D0C-85EE-AACD4C799833Q33668524-222C0DE8-E892-4D38-B85E-F9FD0E70D2CEQ33716535-2A0E2ED0-D1BC-4A34-AF42-9E2B736995EAQ33753905-26EEB285-284E-4A22-8F1E-29A1AA80C2FFQ33802147-6CB36FD9-8639-41D4-BE32-D86B33E6B014Q33810823-97D7F7D8-E2BD-41F2-B83B-461D5F481D5EQ33827836-FE52FD95-090E-4403-BB83-1A9F2C6CBD34Q33873986-BE62EBAA-1DD5-4E55-816B-CCEAB2DBDD98Q33938797-C50E9E7C-8D23-450A-A4EC-1E13EF4FA9B9Q33975593-32F5E57E-985A-445F-BC9D-ADC00BBE41ADQ33997400-954A0337-7715-47B9-A61F-1A36DD568275Q34019885-D6062E13-460B-43E7-AECC-821970A469EFQ34051246-17E67213-E18B-405C-9986-9AA84376680EQ34104857-9EE177AF-2FCE-4FCA-8D48-E6CB191365F2Q34148291-F565A461-913D-46FA-A6CD-5BE56679C272Q34173588-FDB5CE68-F33B-4953-9BC7-A8A6635D9DCAQ34372330-0ECB171B-BB13-43DD-9045-6DDD187A5F9AQ34424535-50924E7C-B8C3-4EEC-8EA1-4E5E9CA8E639Q34427687-712266C0-FE03-4B27-9FCF-7C7F6FF7A851Q34472398-C7A7CFE5-1F0D-4D0E-AF71-90AAE79AF722Q34508737-308205A0-E462-4A21-A487-3C78CEC4FF4EQ34591725-8869ED16-B713-4828-B8B9-652D9D74D02AQ34748127-F3671639-275B-4015-8D3B-92ECD4A7FC7EQ34764377-9F9BBA15-53FB-4B61-9AAE-1C77A0BFEEEBQ34774857-8B3D99A2-AC3F-458B-9FD5-0022C8C6A4C2Q34781053-0DF4D7D3-55BF-4EEB-8B5B-A2960182B492Q34798733-850547C9-5EC4-4394-871C-E593C9B4E063Q34984627-DB6CE446-963B-430C-9C0A-C1AE186674B1Q35008371-A49A2231-7864-450D-B409-26FB71347BF2Q35019895-1E3697FD-4D38-49C1-9781-6AB0E52BC6CEQ35019900-851DEC5F-3304-445A-B2BB-FCCA55DF219FQ35100296-DCC32AF6-7FC2-4137-B620-34F9B3B3805B
P2860
Racial and gender disparities in receipt of highly active antiretroviral therapy persist in a multistate sample of HIV patients in 2001.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Racial and gender disparities ...... ample of HIV patients in 2001.
@en
type
label
Racial and gender disparities ...... ample of HIV patients in 2001.
@en
prefLabel
Racial and gender disparities ...... ample of HIV patients in 2001.
@en
P2093
P1476
Racial and gender disparities ...... ample of HIV patients in 2001.
@en
P2093
Erin D Reilly
Fred J Hellinger
HIV Research Network
Haya R Rubin
James Hellinger
John A Fleishman
Kelly A Gebo
Lawrence Crane
P Todd Korthuis
Philip Keiser
P304
P356
10.1097/00126334-200501010-00017
P407
P577
2005-01-01T00:00:00Z